---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-012333"
form_type: "8-K"
ticker: null
cik: "0000859737"
company_name: "HOLOGIC INC"
filed_at: "2025-04-04T23:59:59+00:00"
generated_at: "2026-05-23T21:56:56.418867+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Hologic appoints Wayde McMillan to Board of Directors

## Summary
- Wayde McMillan, current CFO of Solventum, appointed to Hologic's Board effective April 4, 2025.
- Also appointed to the Audit and Finance Committee.
- Board size increased from eight to nine directors.
- McMillan previously held CFO roles at Insulet and Medtronic's Minimally Invasive Therapies Group.

## SEC filing metadata
- accession: 0001140361-25-012333
- form_type: 8-K
- cik: 0000859737
- company_name: HOLOGIC INC
- filed_at: 2025-04-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/859737/000114036125012333/0001140361-25-012333-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/859737/000114036125012333/ef20046823_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-012333
- JSON: https://secwatch.observer/filing/0001140361-25-012333.json
- Plain text: https://secwatch.observer/filing/0001140361-25-012333.txt

## Key facts
- Executive change
  Wayde McMillan was appointed as Director at HOLOGIC INC.
  - Action: appointed
  - Role: Director
  source text: increased the size of the Board from eight to nine directors and appointed Wayde McMillan as a director of the Company, effective April 4, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/859737/000114036125012333/0001140361-25-012333-index.htm
- Executive change
  Wayde McMillan was appointed as director at HOLOGIC INC.
  - Action: appointed
  - Role: director
  source text: appointed Wayde McMillan as a director of the Company, effective April 4, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/859737/000114036125012333/0001140361-25-012333-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.